Financial reports
NT 10-K
Notice of late annual filing
4 May 15
10-Q
2015 Q3
Quarterly report
22 Dec 14
NT 10-Q
Notice of late quarterly filing
15 Dec 14
10-Q
2015 Q2
Quarterly report
29 Sep 14
NT 10-Q
Notice of late quarterly filing
15 Sep 14
10-Q
2014 Q1
Quarterly report
24 Jul 14
10-K
2014 FY
Annual report
2 Jul 14
NT 10-Q
Notice of late quarterly filing
16 Jun 14
NT 10-K
Notice of late annual filing
1 May 14
Current reports
8-K
Termination of a Material Definitive Agreement
11 Apr 16
8-K
Changes in Registrant's Certifying Accountant
4 Apr 16
8-K
Amendments to Articles of Incorporation or Bylaws
11 Mar 16
8-K
Other Events
1 Aug 14
8-K
Changes in Registrant's Certifying Accountant
8 Jul 14
8-K
Departure of Directors or Certain Officers
4 Mar 14
8-K/A
Entry into a Material Definitive Agreement
27 Feb 14
8-K
Unregistered Sales of Equity Securities
6 Feb 14
8-K
Entry into a Material Definitive Agreement
20 Dec 13
8-K
Departure of Directors or Certain Officers
1 May 13
Registration and prospectus
S-8
Registration of securities for employees
3 Dec 14
8-A12G
Registration of securities
15 Jun 12
424B3
Prospectus supplement
1 Jun 12
424B3
Prospectus supplement
30 May 12
424B3
Prospectus supplement
15 Mar 12
424B3
Prospectus supplement
8 Sep 11
S-1/A
IPO registration (amended)
30 Aug 11
S-1/A
IPO registration (amended)
27 Jul 11
S-1
IPO registration
17 May 11
Proxies
No filings
Ownership
SC 13D
Immunoclin Corp
20 Apr 16
SC 13D
Immunoclin Corp
14 Apr 16
3
Initial statement of insider ownership
1 Apr 16
4
Change in insider ownership
1 Apr 16
SC 13D
Immunoclin Corp
29 Mar 16
SC 13D
Immunoclin Corp
29 Mar 16
SC 13D
Immunoclin Corp
29 Mar 16
SC 13D
Immunoclin Corp
29 Mar 16
3/A
DH Bray
18 Jun 15
4/A
DH Bray
18 Jun 15